BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 25811199)

  • 1. Management of patients with hepatic metastases from neuroendocrine tumors.
    Clift AK; Frilling A
    Ann Saudi Med; 2014; 34(4):279-90. PubMed ID: 25811199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic strategies for neuroendocrine liver metastases.
    Frilling A; Clift AK
    Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of advanced neuroendocrine tumors with hepatic metastasis.
    Khasraw M; Gill A; Harrington T; Pavlakis N; Modlin I
    J Clin Gastroenterol; 2009 Oct; 43(9):838-47. PubMed ID: 19654558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
    Kvols LK; Turaga KK; Strosberg J; Choi J
    J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine liver metastases.
    Reddy SK; Clary BM
    Surg Clin North Am; 2010 Aug; 90(4):853-61. PubMed ID: 20637952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.
    Alagusundaramoorthy SS; Gedaly R
    World J Gastroenterol; 2014 Oct; 20(39):14348-58. PubMed ID: 25339822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of pancreatic neuroendocrine tumors.
    Dickson PV; Behrman SW
    Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging approaches in the management of patients with neuroendocrine liver metastasis: role of liver-directed and systemic therapies.
    Mayo SC; Herman JM; Cosgrove D; Bhagat N; Kamel I; Geschwind JF; Pawlik TM
    J Am Coll Surg; 2013 Jan; 216(1):123-34. PubMed ID: 23063263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for unresectable neuroendocrine liver metastases.
    John BJ; Davidson BR
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):357-69. PubMed ID: 22646257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of liver metastases in patients with digestive neuroendocrine tumors.
    Rossi RE; Massironi S; Spampatti MP; Conte D; Ciafardini C; Cavalcoli F; Peracchi M
    J Gastrointest Surg; 2012 Oct; 16(10):1981-92. PubMed ID: 22829240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
    Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
    Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for management of patients with neuroendocrine liver metastases.
    Frilling A; Modlin IM; Kidd M; Russell C; Breitenstein S; Salem R; Kwekkeboom D; Lau WY; Klersy C; Vilgrain V; Davidson B; Siegler M; Caplin M; Solcia E; Schilsky R;
    Lancet Oncol; 2014 Jan; 15(1):e8-21. PubMed ID: 24384494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioembolization in the treatment of neuroendocrine tumors of the pancreas.
    John PK; Saif MW
    JOP; 2014 Jul; 15(4):332-4. PubMed ID: 25076336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.
    Atwell TD; Charboneau JW; Que FG; Rubin J; Lewis BD; Nagorney DM; Callstrom MR; Farrell MA; Pitot HC; Hobday TJ
    Cardiovasc Intervent Radiol; 2005; 28(4):409-21. PubMed ID: 16041556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal management of neuroendocrine liver metastases.
    Frilling A; Sotiropoulos GC; Li J; Kornasiewicz O; Plöckinger U
    HPB (Oxford); 2010 Aug; 12(6):361-79. PubMed ID: 20662787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of neuroendocrine hepatic metastases.
    Madoff DC; Gupta S; Ahrar K; Murthy R; Yao JC
    J Vasc Interv Radiol; 2006 Aug; 17(8):1235-49; quiz 1250. PubMed ID: 16923972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial embolization in patients with neuroendocrine tumors.
    Del Prete M; Fiore F; Modica R; Marotta V; Marciello F; Ramundo V; Di Sarno A; Carratù A; di Roseto Cde L; Tafuto S; Tatangelo F; Baldelli R; Colao A; Faggiano A;
    J Exp Clin Cancer Res; 2014 May; 33(1):43. PubMed ID: 24887262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic alternatives in metastatic neuroendocrine tumors.
    Miller CA; Ellison EC
    Surg Oncol Clin N Am; 1998 Oct; 7(4):863-79. PubMed ID: 9735138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there still a role for the hepatic locoregional treatment of metastatic neuroendocrine tumors in the era of systemic targeted therapies?
    Cavalcoli F; Rausa E; Conte D; Nicolini AF; Massironi S
    World J Gastroenterol; 2017 Apr; 23(15):2640-2650. PubMed ID: 28487601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.